Skip to main content

generative-ai

Affinity Groups

There are no Affinity Groups associated with this topic. View All Affinity Groups.

Announcements

There are no announcements with this tag. View All Announcements.

Upcoming Events & Trainings

Topics from Ask.CI

Loading topics from Ask.CI ...

Engagements

Re-engineering Lilly’s KisunlaTM into a novel antibody targeting IL13RA2 against GBM using AI-driven macromolecular modeling
Atrium Health Levine Cancer
  • Summary and objectives of the proposed experiments: 
  1. An initial research-based Ab (scFv47, discovered by our collaborator Dr. Balyasnikova) model, modeling Ab-Ag (IL13RA2 against GBM) protein complex, and identifying the binding sites (epitopes) using ROSETTA and AlphaFold2 multimer tools.
  2. Graft the CDRs of scFv (single-chain variable fragment) of antibody or Bispecific T cell engagers (BTEs) onto the template Ab, the framework of Lilly's Kisunla™ Ab drug.
  3. Modify, improve, and optimize the overall or full antibody protein structures using AI-driven macromolecule modeling (AlphaFold3).
  4. Explore single nucleotide polymorphism (SNP), pathogenic genetic variants and N-glycosylation of IL13RA2 (target) protein domain interacting with the Ab candidates among the patient population using ROSETTA software packages.
Status: In Progress

People with Expertise

Calloway Sutton

Indiana University

Programs

ACCESS CSSN

Roles

cssn

Placeholder headshot

Expertise

Fan Chen

Programs

ACCESS CSSN

Roles

mentor, cssn, CIP

Placeholder headshot

Expertise

Feseha Abebe-Akele

Elizabeth City State University

Programs

CCMNet

Roles

mentor, researcher/educator, research computing facilitator, CCMNet

Feseha Abebe-Akele

Expertise

People with Interest

Mohsen Ahmadkhani

Programs

CCMNet, ACCESS CSSN

Roles

student-facilitator, mentor, cssn, CCMNet

Mohsen Ahmadkhani

Interests

Programs

CCMNet

Roles

CCMNet

Interests

Oriana Silva

University of North Texas

Programs

ACCESS CSSN

Roles

student-facilitator

Oriana Silva

Interests